JANA HANEY: Open Payments
NPI 1558923227 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,690 in 62 payments from 21 companies in 2025. Trend: 2023 $302 · 2024 $428 · 2025 $1,690
Food & beverage: $1,520Education: $169
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $255 |
| Verona Pharma, Inc. | 6 | $242 |
| AstraZeneca Pharmaceuticals LP | 6 | $161 |
| Lilly USA, LLC | 2 | $126 |
| GENZYME CORPORATION | 5 | $121 |
| Actelion Pharmaceuticals US, Inc. | 5 | $120 |
| GlaxoSmithKline, LLC. | 5 | $98 |
| Pulmonx Corporation | 3 | $88 |
| Viatris Specialty LLC | 3 | $80 |
| SANOFI-AVENTIS U.S. LLC | 1 | $70 |
Products named: DUPIXENT, Ohtuvayre, TEZSPIRE, CHARTIS CATHETER, TRELEGY ELLIPTA, YUPELRI, OPSYNVI, Arikayce.
Industry payments across AZ — which companies pay providers there.
